H. Nobuko Et Al. , "EFFICACY AND SAFETY OF NILOTINIB IN PEDIATRIC PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE (Ph) CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 2 TRIAL," SIOP , 2017
Nobuko, H. Et Al. 2017. EFFICACY AND SAFETY OF NILOTINIB IN PEDIATRIC PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE (Ph) CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 2 TRIAL. SIOP .
Nobuko, H., Maschan, A., Rizzari, C., Shimada, H., Dufour, C., Goto, H., ... Jin Kang, H.(2017). EFFICACY AND SAFETY OF NILOTINIB IN PEDIATRIC PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE (Ph) CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 2 TRIAL . SIOP
Nobuko, Hijiya Et Al. "EFFICACY AND SAFETY OF NILOTINIB IN PEDIATRIC PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE (Ph) CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 2 TRIAL," SIOP, 2017
Nobuko, Hijiya Et Al. "EFFICACY AND SAFETY OF NILOTINIB IN PEDIATRIC PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE (Ph) CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 2 TRIAL." SIOP , 2017
Nobuko, H. Et Al. (2017) . "EFFICACY AND SAFETY OF NILOTINIB IN PEDIATRIC PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE (Ph) CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 2 TRIAL." SIOP .
@conferencepaper{conferencepaper, author={Hijiya Nobuko Et Al. }, title={EFFICACY AND SAFETY OF NILOTINIB IN PEDIATRIC PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE (Ph) CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 2 TRIAL}, congress name={SIOP}, city={}, country={}, year={2017}}